Help | RSS Feed

Alterity Therapeutics Limited (NASD:ATHE) Seasonal Chart

ATHE Relative to the S&P 500
ATHE Relative to the S&P 500

ATHE Relative to the Sector
ATHE Relative to the Sector

Monthly Seasonal Alterity Therapeutics Limited (NASD:ATHE)

Seasonal Chart Analysis

Analysis of the Alterity Therapeutics Limited (NASD:ATHE) seasonal charts above shows that a Buy Date of June 17 and a Sell Date of September 21 has resulted in a geometric average return of 27.54% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 37.6% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson’s disease gastrointestinal neuropathology. The company’s lead drug candidate-PBT2 is being developed for the treatment of Alzheimer’s and Huntington’s diseases. It has also advanced a drug candidate for Parkinson’s disease and other movement disorders (ATH434).

To download ATHE seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z